(Q44757769)

6 December 2017

title

High-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphoma (English)

1 reference

6 December 2017

1 reference

1 reference

Lauren M Gerard

1

1 reference

6 December 2017

Kevin R Imrie

2

1 reference

6 December 2017

Joy Mangel

3

1 reference

6 December 2017

Rena Buckstein

4

1 reference

6 December 2017

Mary Doherty

5

1 reference

6 December 2017

Robert Mackenzie

6

1 reference

6 December 2017

Matthew C Cheung

7

1 reference

6 December 2017

publication date

12 June 2011

1 reference

6 December 2017

1 reference

6 December 2017

volume

52

1 reference

6 December 2017

issue

10

1 reference

6 December 2017

page(s)

1882-1890

1 reference

Temporal trends in incidence of primary brain tumors in the United States, 1985-1999

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

Decreasing incidence rates of primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

Cerebrospinal fluid concentrations of vincristine after bolus intravenous dosing: a surrogate marker of brain penetration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: a pilot study of the BOMES protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

Response criteria for phase II studies of supratentorial malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

Chemotherapy as first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

Therapy of primary central nervous system lymphoma with pre-irradiation methotrexate, cyclophosphamide, doxorubicin, vincristine, and dexamethasone (MCHOD).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

PROMACE-MOPP and intrathecal chemotherapy for CNS lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

Successful treatment of non-Hodgkin's lymphoma of the central nervous system with BMPD chemotherapy followed by radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

Short intensive primary chemotherapy and radiotherapy in sporadic primary CNS lymphoma (PCL).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

Treatment for primary CNS lymphoma: the next step

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.584004

10.3109/10428194.2011.584004

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference